ASSEMBLY BIOSCIENCES, INC. Cash Flow Statement
ASMB|1 years of annual SEC 10-K data (FY2025-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid. All figures from audited SEC 10-K filings.
ASSEMBLY BIOSCIENCES, INC. used $41M in operating cash flow and negative free cash flow of $41M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -0.32 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 |
|---|---|
| Net Income | -$6.1M |
| Depreciation & Amortization | $129.0K |
| Operating Cash Flow | -$41.1M |
| Capital Expenditures | $66.0K |
| Free Cash Flow | -$41.2M |
| FCF Margin | -56.9% |